Marlowe (LON:MRL) Trading Down 0.3% – Should You Sell?

Marlowe plc (LON:MRL)’s stock price was down 0.3% on Monday . The stock traded as low as GBX 318 ($4.03) and last traded at GBX 318 ($4.03). Approximately 435,519 shares were traded during mid-day trading, a decline of 29% from the average daily volume of 613,986 shares. The stock had previously closed at GBX 319 ($4.05).

Analyst Upgrades and Downgrades

Separately, Berenberg Bank restated a “buy” rating and issued a GBX 710 ($9.01) price objective on shares of Marlowe in a report on Wednesday, August 21st.

Marlowe Price Performance

The stock has a market cap of £278.92 million, a P/E ratio of -2,271.43 and a beta of 0.44. The company has a debt-to-equity ratio of 58.99, a quick ratio of 0.80 and a current ratio of 1.24. The firm has a 50-day moving average price of GBX 334.56 and a 200-day moving average price of GBX 411.61.

Insider Buying and Selling

In other Marlowe news, insider Peter M. R. Gaze acquired 15,000 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were acquired at an average price of GBX 309 ($3.92) per share, with a total value of £46,350 ($58,804.87). 25.30% of the stock is owned by insiders.

Marlowe Company Profile

Marlowe plc provides compliance services and software in the United Kingdom. The company operates in two segments, Governance, Risk and Compliance; and Testing, and Inspection and Certification. It offers health and safety consultancy, risk and audit assessments, environmental, contractor management, and training services; and health and safety support services.